In conversation with...
The Lancet Respiratory Medicine
Editors speak to the journal’s authors to explore their research and its impact on people’s health, health care, and health policy in this regular podcast.
Episodes
Richard Costello on management of uncontrolled asthmaMarch 21, 2023
Keiju Aokage on segmentectomy for ground-glass-dominant lung cancerMarch 06, 2023
Carol Hodgson on post-discharge outcomes for ECMO patientsFebruary 09, 2023
Emma Grainger on 10 years of The Lancet Respiratory MedicineDecember 22, 2022
Vivienne Kahlmann and Catharina Moor on the TIRED studyNovember 23, 2022
Yves Lacasse on long-term oxygen therapy for COPDAugust 01, 2022
Rachael Evans on living with long COVIDJuly 26, 2022
Daniel Munblit and Dale Needham on core outcomes post-COVID-19June 15, 2022
Daiana Stolz on antibiotic stewardship in pneumoniaMay 24, 2022
Ablo Wachinou on sleep disordered breathing in BeninApril 08, 2022
Peter Openshaw and Felicity Liew on corticosteroids in the early in the treatment of COVIDApril 07, 2022
Dinh Bui on preterm birth and lung function deficits February 18, 2022
Ruvim Izĭckson on a joint flu and COVID-19 vaccineJanuary 31, 2022
Wisia Wedzicha on a vaccine for COPDJanuary 11, 2022
Eileen Rubin on patient-centered ARDSDecember 30, 2021
Daniel Altmann on COVID boostersNovember 30, 2021
Michael Kreuter on interstitial lung diseaseSeptember 07, 2021
Bairbre McNicholas and Jie Li on awake prone positioning and COVID-19August 21, 2021
Charles Sprung and authors on end-of-life practices in ICUs globallyAugust 04, 2021
Christopher Brightling on tezepelumab in patients with moderate-to-severe uncontrolled asthmaJuly 11, 2021
Paul Verweij on COVID-19 associated aspergillosisMay 27, 2021
Ignacio Rubio on COVID-19 pathophysiology and phenotypesMay 18, 2021
Kiran Shekar on cytokine adsorption and severe COVID-19 pneumoniaMay 15, 2021
Fan Chung on chronic cough and long COVID May 11, 2021
Mepolizumab and the treatment of chronic rhinosinusitisApril 17, 2021